Literature DB >> 29754210

Invasive pulmonary aspergillosis: current diagnostic methodologies and a new molecular approach.

S Moura1,2, L Cerqueira2,3, A Almeida4.   

Abstract

The fungus Aspergillus fumigatus is the main pathogenic agent responsible for invasive pulmonary aspergillosis. Immunocompromised patients are more likely to develop this pathology due to a decrease in the immune system's defense capacity. Despite of the low occurrence of invasive pulmonary aspergillosis, this pathology presents high rates of mortality, mostly due to late and unspecific diagnosis. Currently, the diagnostic methods used to detect this fungal infection are conventional mycological examination (direct microscopic examination, histological examination, and culture), imaging, non-culture-based tests for the detection of galactomannan, β(1,3)-glucan and an extracellular glycoprotein, and molecular tests based on PCR. However, most of these methods do not detect the species A. fumigatus; they only allow the identification of genus Aspergillus. The development of more specific detection methods is of extreme importance. Fluorescent in situ hybridization-based molecular methods can be a good alternative to achieve this purpose. In this review, it is intended to point out that most of the methods used for the diagnosis of invasive pulmonary aspergillosis do not allow to detect the fungus at the species level and that fluorescence in situ hybridization-based molecular method will be a promising approach in the A. fumigatus detection.

Entities:  

Keywords:  Aspergillosis; Diagnostic methodologies; Fluorescence in situ hybridization; Invasive pulmonary

Mesh:

Substances:

Year:  2018        PMID: 29754210     DOI: 10.1007/s10096-018-3251-5

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  79 in total

Review 1.  The identification of microorganisms by fluorescence in situ hybridisation.

Authors:  R Amann; B M Fuchs; S Behrens
Journal:  Curr Opin Biotechnol       Date:  2001-06       Impact factor: 9.740

2.  False-positive plasma (1-->3)-beta-D-glucan test following immunoglobulin product replacement in an adult bone marrow recipient.

Authors:  Masahiro Ogawa; Hiroki Hori; Shigeko Niiguchi; Eiichi Azuma; Yoshihiro Komada
Journal:  Int J Hematol       Date:  2004-07       Impact factor: 2.490

Review 3.  Aspergillus fumigatus: contours of an opportunistic human pathogen.

Authors:  Allison McCormick; Jürgen Loeffler; Frank Ebel
Journal:  Cell Microbiol       Date:  2010-09-16       Impact factor: 3.715

Review 4.  Pathogenesis of Aspergillus fumigatus in Invasive Aspergillosis.

Authors:  Taylor R T Dagenais; Nancy P Keller
Journal:  Clin Microbiol Rev       Date:  2009-07       Impact factor: 26.132

5.  Release of (1-->3)-beta-D-glucan from depth-type membrane filters and their in vitro effects on proinflammatory cytokine production.

Authors:  Atsushi Ohata; Makoto Usami; Takashi Horiuchi; Koichi Nagasawa; Keiko Kinoshita
Journal:  Artif Organs       Date:  2003-08       Impact factor: 3.094

6.  Diagnostic performance of the (1-->3)-beta-D-glucan assay for invasive fungal disease.

Authors:  Sophia Koo; Julie M Bryar; John H Page; Lindsey R Baden; Francisco M Marty
Journal:  Clin Infect Dis       Date:  2009-12-01       Impact factor: 9.079

7.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Authors:  Ben De Pauw; Thomas J Walsh; J Peter Donnelly; David A Stevens; John E Edwards; Thierry Calandra; Peter G Pappas; Johan Maertens; Olivier Lortholary; Carol A Kauffman; David W Denning; Thomas F Patterson; Georg Maschmeyer; Jacques Bille; William E Dismukes; Raoul Herbrecht; William W Hope; Christopher C Kibbler; Bart Jan Kullberg; Kieren A Marr; Patricia Muñoz; Frank C Odds; John R Perfect; Angela Restrepo; Markus Ruhnke; Brahm H Segal; Jack D Sobel; Tania C Sorrell; Claudio Viscoli; John R Wingard; Theoklis Zaoutis; John E Bennett
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

Review 8.  Many faces of pulmonary aspergillosis.

Authors:  O P Sharma; R Chwogule
Journal:  Eur Respir J       Date:  1998-09       Impact factor: 16.671

9.  False-positive results of Aspergillus galactomannan antigenemia in liver transplant recipients.

Authors:  Jesus Fortún; Pilar Martín-Dávila; Maria E Alvarez; Francesca Norman; Aurora Sánchez-Sousa; Luis Gajate; Rafael Bárcena; S Javier Nuño; Santiago Moreno
Journal:  Transplantation       Date:  2009-01-27       Impact factor: 4.939

10.  Influence of host immunosuppression on CT findings in invasive pulmonary aspergillosis.

Authors:  Miguel A Milito; Dimitrios P Kontoyiannis; Russell E Lewis; Ping Liu; Osama R Mawlawi; Mylene T Truong; Edith M Marom
Journal:  Med Mycol       Date:  2010-09       Impact factor: 4.076

View more
  3 in total

1.  Two Monoclonal Antibodies That Specifically Recognize Aspergillus Cell Wall Antigens and Can Detect Circulating Antigens in Infected Mice.

Authors:  Xihua Lian; Stephen Chambers; John G Lewis; Amy Scott-Thomas; Madhav Bhatia
Journal:  Int J Mol Sci       Date:  2021-12-27       Impact factor: 5.923

2.  Comparison of the Performance of Two Galactomannan Detection Tests: Platelia Aspergillus Ag and Aspergillus Galactomannan Ag Virclia Monotest.

Authors:  Alba Leyva Calero; Roberto Alonso; Ignacio Gadea; María Dolores Montero Vega; Marta Martín García; Patricia Muñoz; Marina Machado; Emilio Bouza; Julio García-Rodríguez
Journal:  Microbiol Spectr       Date:  2022-03-09

3.  Subdiffraction-resolution fluorescence imaging of immunological synapse formation between NK cells and A. fumigatus by expansion microscopy.

Authors:  Nora Trinks; Sebastian Reinhard; Matthias Drobny; Linda Heilig; Jürgen Löffler; Markus Sauer; Ulrich Terpitz
Journal:  Commun Biol       Date:  2021-10-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.